HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)

HLB Therapeutics Revenue

HLB Therapeutics had revenue of 15.05B KRW in the quarter ending March 31, 2025, with 17.97% growth. This brings the company's revenue in the last twelve months to 57.22B, up 2.19% year-over-year. In the year 2024, HLB Therapeutics had annual revenue of 54.93B with 4.45% growth.

• Revenue (ttm): 57.22B
• Revenue Growth: +2.19%
• P/S Ratio: 6.03
• Revenue / Employee: 1.19B
• Employees: 48
• Market Cap: 345.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	54.93B	2.34B	4.45%
Dec 31, 2023	52.59B	10.19B	24.03%
Dec 31, 2022	42.40B	-1.18B	-2.72%
Dec 31, 2021	43.59B	656.63M	1.53%
Dec 31, 2020	42.93B	-16.04B	-27.20%